Search Page

1

Cite

Share

Effect of acetazolamide on visual function in patients with idiopathic intracranial hypertension and mild visual loss: the idiopathic intracranial hypertension treatment trial.

NORDIC Idiopathic Intracranial Hypertension Study Group Writing Committee, Wall M, McDermott MP, Kieburtz KD, Corbett JJ, Feldon SE, Friedman DI, Katz DM, Keltner JL, Schron EB, Kupersmith MJ. NORDIC Idiopathic Intracranial Hypertension Study Group Writing Committee, et al. Among authors: kieburtz kd. JAMA. 2014 Apr 23-30;311(16):1641-51. doi: 10.1001/jama.2014.3312. JAMA. 2014. PMID: 24756514 Free PMC article. Clinical Trial.

Cite

Share

2

Cite

Share

Headache and the human immunodeficiency virus type 1 infection.

Holloway RG, Kieburtz KD. Holloway RG, et al. Among authors: kieburtz kd. Headache. 1995 May;35(5):245-55. doi: 10.1111/j.1526-4610.1995.hed3505245.x. Headache. 1995. PMID: 7775185 Review.

Cite

Share

3

Cite

Share

Adverse event reporting in clinical trials in Parkinson's Disease: Time for change.

Olanow CW, Kenney C, Bandak S, Kieburtz KD. Olanow CW, et al. Among authors: kieburtz kd. Mov Disord. 2018 Nov;33(11):1685-1687. doi: 10.1002/mds.27497. Epub 2018 Nov 1. Mov Disord. 2018. PMID: 30383315 No abstract available.

Cite

Share

4

Cite

Share

Excitotoxicity and dopaminergic dysfunction in the acquired immunodeficiency syndrome dementia complex. Therapeutic implications.

Kieburtz KD, Epstein LG, Gelbard HA, Greenamyre JT. Kieburtz KD, et al. Arch Neurol. 1991 Dec;48(12):1281-4. doi: 10.1001/archneur.1991.00530240087028. Arch Neurol. 1991. PMID: 1845034 Review.

Cite

Share

5

Cite

Share

Prospective evaluation of pulmonary function in Parkinson's disease patients with motor fluctuations.

Hampson NB, Kieburtz KD, LeWitt PA, Leinonen M, Freed MI. Hampson NB, et al. Among authors: kieburtz kd. Int J Neurosci. 2017 Mar;127(3):276-284. doi: 10.1080/00207454.2016.1194274. Epub 2016 Jun 27. Int J Neurosci. 2017. PMID: 27345931 Clinical Trial.

Cite

Share

6

Cite

Share

Motor, cognitive, and functional declines contribute to a single progressive factor in early HD.

Schobel SA, Palermo G, Auinger P, Long JD, Ma S, Khwaja OS, Trundell D, Cudkowicz M, Hersch S, Sampaio C, Dorsey ER, Leavitt BR, Kieburtz KD, Sevigny JJ, Langbehn DR, Tabrizi SJ; TRACK-HD, COHORT, CARE-HD, and 2CARE Huntington Study Group Investigators. Schobel SA, et al. Among authors: kieburtz kd. Neurology. 2017 Dec 12;89(24):2495-2502. doi: 10.1212/WNL.0000000000004743. Epub 2017 Nov 15. Neurology. 2017. PMID: 29142089 Free PMC article.

Cite

Share

7

Cite

Share

Predictors of time to initiation of symptomatic therapy in early Parkinson's disease.

Simuni T, Long JD, Caspell-Garcia C, Coffey CS, Lasch S, Tanner CM, Jennings D, Kieburtz KD, Marek K; PPMI Investigators. Simuni T, et al. Among authors: kieburtz kd. Ann Clin Transl Neurol. 2016 May 17;3(7):482-94. doi: 10.1002/acn3.317. eCollection 2016 Jul. Ann Clin Transl Neurol. 2016. PMID: 27386498 Free PMC article.

Cite

Share

8

Cite

Share

Robust Bayesian inference for multivariate longitudinal data by using normal/independent distributions.

Luo S, Ma J, Kieburtz KD. Luo S, et al. Among authors: kieburtz kd. Stat Med. 2013 Sep 30;32(22):3812-28. doi: 10.1002/sim.5778. Epub 2013 Mar 11. Stat Med. 2013. PMID: 23494809 Free PMC article.

Cite

Share

9

Cite

Share

Suicidality Risk Factors Across the CARE-HD, 2CARE, and CREST-E Clinical Trials in Huntington Disease.

McGarry A, Auinger P, Kieburtz KD, Bredlau AL, Hersch SM, Rosas HD. McGarry A, et al. Among authors: kieburtz kd. Neurol Clin Pract. 2022 Apr;12(2):131-138. doi: 10.1212/CPJ.0000000000001161. Neurol Clin Pract. 2022. PMID: 35747889

Cite

Share

10

Cite

Share

A randomized trial of inhaled levodopa (CVT-301) for motor fluctuations in Parkinson's disease.

LeWitt PA, Hauser RA, Grosset DG, Stocchi F, Saint-Hilaire MH, Ellenbogen A, Leinonen M, Hampson NB, DeFeo-Fraulini T, Freed MI, Kieburtz KD. LeWitt PA, et al. Among authors: kieburtz kd. Mov Disord. 2016 Sep;31(9):1356-65. doi: 10.1002/mds.26611. Epub 2016 Apr 19. Mov Disord. 2016. PMID: 27090868 Clinical Trial.

Cite

Share